GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$607M
AUM Growth
-$499M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$38.4M
2
+$17.7M
3
+$15.3M
4
TBPH icon
Theravance Biopharma
TBPH
+$14.7M
5
ARVN icon
Arvinas
ARVN
+$13.9M

Top Sells

1
+$137M
2
+$131M
3
+$74.5M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$64.2M
5
CYTK icon
Cytokinetics
CYTK
+$55.2M

Sector Composition

1 Healthcare 93.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$45M 7.31%
390,000
-130,232
2
$42.6M 6.91%
917,427
-2,959,173
3
$39.3M 6.39%
454,417
-1,512,271
4
$38.5M 6.26%
720,502
-1,201,061
5
$38.4M 6.24%
+700,000
6
$37.8M 6.14%
799,722
-768,178
7
$29.8M 4.85%
1,302,871
+554,945
8
$29.5M 4.79%
1,024,800
-1,837,124
9
$28.3M 4.6%
1,239,287
-270,928
10
$27.8M 4.51%
900,000
-580,787
11
$26.5M 4.31%
345,120
-651,778
12
$25.8M 4.19%
595,473
-60,203
13
$22.8M 3.7%
150,000
-490,773
14
$17.7M 2.88%
+856,162
15
$16.9M 2.75%
4,083,909
+1,583,909
16
$15.3M 2.49%
+60,000
17
$14.7M 2.38%
+824,580
18
$13.9M 2.26%
+164,150
19
$13.3M 2.17%
1,300,000
+197,927
20
$13M 2.11%
+19,498
21
$11.7M 1.91%
977,647
-570,832
22
$9.53M 1.55%
+475,000
23
$9.06M 1.47%
92,250
-53,679
24
$8.44M 1.37%
+421,383
25
$8.25M 1.34%
+236,400
1
2